Reichle G, Freitag L, Kullmann H J, Prenzel R, Macha H N, Farin G
Lungenklinik Hemer, Pneumologische Abteilung, Hemer.
Pneumologie. 2000 Nov;54(11):508-16. doi: 10.1055/s-2000-8254.
Argon plasma coagulation (APC) is a thermal coagulation technique that uses ionized argon to transmit high-frequency electrical current, contact free, to tissue. APC has been used in surgery for more than 20 years, particularly for the hemostasis of superficial bleeding. Although APC has become well established in gastrointestinal endoscopy since its introduction in 1991, very few reports of its use in bronchoscopy exist to date. From June 1994 to June 1998, 364 patients (80 women, 284 men), 88% with a confirmed malignant tumor, were treated prospectively in a total of 482 sessions. The single most common indication was recanalization of malignant airway stenoses (186 patients). The defined therapy objective was achieved with good results in 67% of patients. More than 90% of interventions were performed with rigid bronchoscopy. Despite less penetration compared with Nd:YAG laser, extensive bronchial tumors were treatable, in which coagulated tumor fractions were removed either with forceps or bronchoscope tip. The second indication was bleeding in the central airways (119 patients). Acute hemostasis was achieved in 118 patients, 20% in whom the flexible technique under local anesthesia was used. In 34 patients, APC was successfully used to recanalize occluded stents. Rare indications included benign endobronchial tumor, fistula conditioning before fibrin adhesion, and the treatment of scar tissue stenosis. Summarizing all complications, a rate of 3.7% "per treatment" was recorded. Two patients died within 24 hours; their deaths were not directly related to APC. APC is an effective and safe technique for the treatment of bronchologic tumor ablation and hemostasis and can be used with local anaesthetic with flexible bronchoscopy or rigid bronchoscopy with general anesthesia. Compared with Nd:YAG laser, APC is an economic alternative technique offering more effective hemostasis. Furthermore, APC is of particular value as a compliment to well-known techniques, increasing the options in interventional bronchoscopy.
氩等离子体凝固术(APC)是一种热凝固技术,它利用电离氩气将高频电流非接触地传输到组织。APC已在外科手术中应用了20多年,尤其用于浅表出血的止血。尽管自1991年引入以来,APC在胃肠内镜检查中已得到广泛应用,但迄今为止,关于其在支气管镜检查中应用的报道却很少。从1994年6月至1998年6月,对364例患者(80例女性,284例男性)进行了前瞻性治疗,共进行了482次治疗,其中88%的患者确诊为恶性肿瘤。最常见的单一适应证是恶性气道狭窄的再通(186例患者)。67%的患者达到了明确的治疗目标,效果良好。超过90%的干预操作是通过硬支气管镜进行的。尽管与Nd:YAG激光相比,其穿透性较小,但广泛的支气管肿瘤仍可治疗,凝固的肿瘤部分可用钳子或支气管镜尖端取出。第二个适应证是中央气道出血(119例患者)。118例患者实现了急性止血,其中20%采用了局部麻醉下的柔性技术。在34例患者中,APC成功用于再通阻塞的支架。罕见的适应证包括良性支气管内肿瘤、纤维蛋白粘连前的瘘管预处理以及瘢痕组织狭窄的治疗。总结所有并发症,“每次治疗”的发生率为3.7%。两名患者在24小时内死亡,他们的死亡与APC无直接关系。APC是一种治疗支气管肿瘤消融和止血的有效且安全的技术,可在局部麻醉下用于柔性支气管镜检查,或在全身麻醉下用于硬支气管镜检查。与Nd:YAG激光相比,APC是一种经济的替代技术,具有更有效的止血效果。此外,APC作为对知名技术的补充具有特殊价值,增加了介入性支气管镜检查的选择。